VEGF-binding fusion proteins and nucleic acids encoding the same
US7399612B2 · kind B2 · utility
52Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2006 |
| Grant date | Jul 15, 2008 |
| Priority date | — |
| Expiry date | Jun 11, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nucleic acid molecules encoding fusion proteins which bind and inhibit vascular endothelial growth factor (VEGF). The VEGF-binding fusion proteins are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.